需有创机械通气的COVID-19患者病死率:一项荟萃分析
该荟萃分析纳入69项研究、共57,420例接受有创机械通气的成人COVID-19患者,旨在评估报告病死率。总体报告病死率估计为45%(95%CI 39-52%)。仅13,120例(22.8%)患者提供了明确的出院结局。年龄分层分析显示,≤40岁患者合并病死率为47.9%(95%CI 46.4-49.4%),>80岁患者为84.4%(95%CI 83.3-85.4%)。早期疫情中心病死率也更高,研究间异质性高(I2>90%)。
要点
- 总体报告病死率45%(95%CI 39-52%),但仅22.8%患者有明确出院结局,报告方法差异导致研究间病死率范围宽。
- 年龄≤40岁患者合并病死率47.9%(95%CI 46.4-49.4%),>80岁患者84.4%(95%CI 83.3-85.4%)。
- 早期疫情中心病死率更高,可能受ICU资源有限影响。
- 研究间异质性高(I2>90%),Egger检验未提示发表偏倚。
- 需对所有患者报告明确结局以利于研究间比较。
适用人群与场景
- 确诊COVID-19并接受有创机械通气的成人患者(年龄≥18岁),纳入69项研究共57,420例。
- 原文未提及排除人群及具体急诊/ICU场景。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与荟萃分析,纳入69项研究,共57,420例接受有创机械通气的成人COVID-19患者;原文未明确单中心或多中心。
- 主要终点:总体报告病死率为45%(95%CI 39-52%)。
- 年龄分层:≤40岁患者合并病死率47.9%(95%CI 46.4-49.4%),>80岁患者84.4%(95%CI 83.3-85.4%)。
- 早期疫情中心病死率更高;总体异质性高(I2>90%),Egger回归检验无显著发表偏倚。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析(PROSPERO注册号CRD42020186997)。
- 证据等级:原文未提及。
- 局限:原文明确述及报告病死率方法差异导致研究间病死率范围宽、仅22.8%患者有明确出院结局、异质性高(I2>90%);原文未述其他局限性。
对床旁实践的改变
- 对于接受有创机械通气的COVID-19成人患者,可参考总体报告病死率约45%进行病情沟通,但需注意研究间报告方法差异大。
- 高龄(>80岁)患者报告病死率可达84.4%,≤40岁患者为47.9%,年龄分层可能影响预后评估。
指南或共识出处
- 原文未提及指南或共识名称;系统评价注册于PROSPERO(CRD42020186997)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Initial reports of case fatality rates (CFRs) among adults with coronavirus disease (COVID-19) receiving invasive mechanical ventilation (IMV) are highly variable.Objectives: To examine the CFR of patients with COVID-19 receiving IMV.Methods: Two authors independently searched PubMed, Embase, medRxiv, bioRxiv, the COVID-19 living systematic review, and national registry databases. The primary outcome was the "reported CFR" for patients with confirmed COVID-19 requiring IMV. "Definitive hospital CFR" for patients with outcomes at hospital discharge was also investigated. Finally, CFR was analyzed by patient age, geographic region, and study quality on the basis of the Newcastle-Ottawa Scale.Measurements and Results: Sixty-nine studies were included, describing 57,420 adult patients with COVID-19 who received IMV. Overall reported CFR was estimated as 45% (95% confidence interval [CI], 39-52%). Fifty-four of 69 studies stated whether hospital outcomes were available but provided a definitive hospital outcome on only 13,120 (22.8%) of the total IMV patient population. Among studies in which age-stratified CFR was available, pooled CFR estimates ranged from 47.9% (95% CI, 46.4-49.4%) in younger patients (age ≤40 yr) to 84.4% (95% CI, 83.3-85.4%) in older patients (age >80 yr). CFR was also higher in early COVID-19 epicenters. Overall heterogeneity is high (I2 >90%), with nonsignificant Egger's regression test suggesting no publication bias.Conclusions: Almost half of patients with COVID-19 receiving IMV died based on the reported CFR, but variable CFR reporting methods resulted in a wide range of CFRs between studies. The reported CFR was higher in older patients and in early pandemic epicenters, which may be influenced by limited ICU resources. Reporting of definitive outcomes on all patients would facilitate comparisons between studies.Systematic review registered with PROSPERO (CRD42020186997).
参考来源
- Lim ZJ, Subramaniam A, Ponnapa Reddy M, et al. Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis. Am J Respir Crit Care Med. 2021. PMID: 33119402. doi:10.1164/rccm.202006-2405OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。